Pancho Villa's Short Analysis File Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pancho Villa's Short Analysis File

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pancho Villa who wrote (36)	10/2/1998 11:11:00 PM
From: TRIIBoy	Read Replies (1) of 287

BFT has been good to me so I thought I might return the favor with Immunex (IMNX) 1)in the next two to three weeks estimates will go down from positive EPS of anywhere from $0.50 to $0.90 to losses. 2)Enbrel drug which company is counting on got a harsh review in FDA review panel in September, very restrictive labelling 3)company needs financing, analysts keeping it above water for juicy secondary 4)FDA has manufacturing concerns, possibility of a delay in November. 5)market cap does not justify the puny 15% margins it could get from Enbrel Enjoy...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next